SCHEMBL9748

SCHEMBL9748

COc1ccc(CNc2nc3ccc(-c4ncccc4C)cc3cc2CC(C)(CCC(C)(C)C)C(N)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.48
CTSD P07339 2/20 0.48
TP53 P04637 2/20 0.37
CLK1 P49759 1/20 0.37
CLK2 P49760 1/20 0.37
DYRK1A Q13627 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
NPC1 O15118 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
ZAP70 P43403 1/20 0.36
KARS1 Q15046 1/20 0.36
AURKA O14965 1/20 0.35
RPS6KB1 P23443 1/20 0.35
CD38 P28907 1/20 0.35
HIF1A Q16665 1/20 0.35
F2 P00734 1/20 0.34
KLKB1 P03952 1/20 0.34
GRM2 Q14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14321873 0.82 BACE1 (0.69) BACE1CTSDCLK1CLK2DYRK1A
SCHEMBL9397 0.79 BACE1 (0.48) BACE1CTSDTP53CLK1CLK2
SCHEMBL9396 0.79 BACE1 (0.48) BACE1CTSDTP53CLK1CLK2
SCHEMBL9061 0.65 BACE1 (1.00) BACE1CTSD
SCHEMBL9166 0.65 BACE1 (1.00) BACE1CTSD
SCHEMBL13960 0.65 MAPT (0.43) TP53NPC1AURKARPS6KB1CD38
SCHEMBL28283742 0.64 NPC1 (0.64) DYRK1ACLK4NPC1HIF1A
SCHEMBL31544178 0.64 PPARA (0.47) TP53
SCHEMBL31544214 0.64 MAPT (0.45) TP53
SCHEMBL31544096 0.63 KMT2A (0.55) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504315-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP disclosed
WO-2011063233-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO disclosed